semaglutide and cardiovascular outcomes in diabetes participants with type 2 #diabetes #kidney disease, consistent benefits of (#ozempic) on major kidney outcomes, major #heart outcomes, and all-cause death were observed regardless of baseline mineralocorticoid antagonist use ( Insights into semaglutide cardiovascular research:

Prolonged and tunable residence time using reversible covalent kinase inhibitors

But the functional answer is nothey do not produce the same biological outcomes, and assuming they do is a category error that wastes time, funding, and experimental animals

Wegovy's standard dosing schedule is a low initial dose of 0.25mg once weekly that is increased every four weeks for 16 weeks to a maximum dose of 2.4mg

This is not an increase in body fat and your weight should return to baseline once your bowel movements resume

The 28-day mark is not a chemical cliff, and a vial punctured twice with good technique is not meaningfully different on day 30 than on day 27

The histidine imidazole ring, glycine amino groups, and deprotonated amide nitrogens coordinate the copper ion, creating a stable chelation complex